Sirona Biochem Announces Positive Results with SBM-TFC-837 for Anti-aging and Regenerative Medicine
Sirona Biochem Announces Successful Development of a Third Skin Lightener with Superior Safety and Efficacy
Sirona Biochem: Positive Preclinical Toxicology Results for its SGLT2 Inhibitor Trigger Milestone Payment from Wanbang Biopharmaceuticals
Sirona Biochem Appoints Dr. Martin Gleave to its Board of Directors
- « Previous Page
- 1
- …
- 28
- 29
- 30
- 31
- 32
- …
- 59
- Next Page »